tiprankstipranks
Alnylam Pharmaceuticals (GB:0HD2)
NASDAQ:0HD2
UK Market
0HD2
Alnylam Pharma
RESEARCH TOOLSreports

Alnylam Pharma (0HD2) Stock News & Sentiment

4 Followers
Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story
Premium
Company Announcements
Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story
10d ago
ALNY
Alnylam Pharmaceuticals: Solid TTR Demand but Near‑Term Headwinds Justify Hold Rating
Premium
Ratings
Alnylam Pharmaceuticals: Solid TTR Demand but Near‑Term Headwinds Justify Hold Rating
12d ago
ALNY
Alnylam Buy Rating Backed by Expanding ATTR-CM Opportunity, Durable Amvuttra Leadership, and Long-Term Growth Visibility
Premium
Ratings
Alnylam Buy Rating Backed by Expanding ATTR-CM Opportunity, Durable Amvuttra Leadership, and Long-Term Growth Visibility
17d ago
ALNY
Alnylam Pharmaceuticals: Underpenetrated TTR Market and Strong Commercial Execution Support Buy Rating
Premium
Ratings
Alnylam Pharmaceuticals: Underpenetrated TTR Market and Strong Commercial Execution Support Buy Rating
17d ago
ALNY
Alnylam Pharmaceuticals: Durable ATTR Growth and Amvuttra Momentum Support Buy Rating and Upside Potential
Premium
Ratings
Alnylam Pharmaceuticals: Durable ATTR Growth and Amvuttra Momentum Support Buy Rating and Upside Potential
17d ago
ALNY
Alnylam Grants CEO New Performance-Based Equity Award
Premium
Company Announcements
Alnylam Grants CEO New Performance-Based Equity Award
1M ago
8K
ALNY
Alnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors
Premium
Company Announcements
Alnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors
1M ago
ALNY
More GB:0HD2 News >

0HD2 News on the Web

RBC Capital Keeps Their Buy Rating on Alnylam Pharma (ALNY)
TipRanks News
Neutral
Top Alnylam Executive Makes Eye-Catching Move With Company Stock
TipRanks News
Neutral
Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?
Zacks
Bearish
BioCryst appoints Sandeep Menon as chief research and development officer
TipRanks News
Neutral
Alnylam Pharma (ALNY) Gets a Buy from Barclays
TipRanks News
Neutral
Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story
TipRanks News
Neutral
Piper Sandler Sticks to Their Buy Rating for Alnylam Pharma (ALNY)
TipRanks News
Neutral
Alnylam presents new data on vutrisiran in ATTR-CM at ACC.26
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
GB:0HD2
Sector Average
Media Buzz
This Week4 articles
Weekly Average7.5 articles
News Sentiment
This Week19%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0HD2’s Media Buzz Sentiment?
4 articles about GB:0HD2 were published this week. In an average week, 7.5 articles are published.
    What is GB:0HD2’s weekly average amount of articles?
    In an average week, 7.5 articles about GB:0HD2 are published.
      What is GB:0HD2’s News Sentiment?
      19% of articles about GB:0HD2 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week